Lincoln Pharmaceuticals Share Price
Know More₹461.30 3.75 (0.82%)
04:01 PM, 1-Feb-2026₹461.05 4.60 (1.01%)
03:51 PM, 1-Feb-2026BSE : 531633
NSE : LINCOLN
Sector : Health care
ISIN Code : INE405C01035
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 01-Feb-2026 | 04:01 PM IST
| Market Cap (₹ Cr) | 924 |
Traded Value (₹ Cr) | 0.03 |
Volume (Shares) | 617 |
Face Value (₹) | 10 |
52-Week High (₹) | 804.70 |
52-Week High Date | 06-Feb-2025 |
52-Week Low (₹) | 439.95 |
52-Week Low Date | 28-Jan-2026 |
All Time High (₹) | 975.00 |
All Time High Date | 09-Dec-2024 |
All Time Low (₹) | 8.05 |
All Time Low Date | 12-Jun-2002 |
Lincoln Pharmaceuticals Ltd
Lincoln Pharmaceuticals Ltd News
Lincoln Pharma. Announcement
Lincoln Pharmaceuticals Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 923 |
| EPS - TTM (₹) [C] | 39.94 |
| P/E Ratio (X) [C] | 11.54 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 18.00 |
| Latest Dividend Date | 12-Sep-2025 |
| Dividend Yield (%) | 0.39 |
| Book Value Share (₹) [C] | 357.35 |
| P/B Ratio (₹) [C] | 1.29 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | 0.01 | 281 | 0.03 |
| Bandhan BSE Healthcare Index Fund - Regular (G) | 0.01 | 122 | 0.03 |
| Bandhan BSE Healthcare Index Fund - Direct (G) | 0.01 | 122 | 0.03 |
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 450.00 464.80 |
| Week Low/High (₹) | 440.00 464.80 |
| Month Low/High (₹) | 440.00 505.00 |
| Year Low/High (₹) | 440.00 809.00 |
| All time Low/High (₹) | 8.05 980.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 1.73% | 1.75% | -1.00% | -0.89% |
| 1 Month | -3.86% | -3.91% | -5.24% | -5.05% |
| 3 Month | -13.13% | -12.98% | -3.83% | -3.49% |
| 6 Month | -13.65% | -13.67% | 0.15% | 1.06% |
| 1 Year | -35.71% | -35.95% | 4.15% | 5.72% |
| 3 Year | 45.08% | 45.12% | 35.20% | 40.92% |
Company Info
Company Information
Chairman (Non-Executive) : Kishorbhai M Shah
Managing Director : Mahendra G Patel
Whole-time Director : Hasmukhbhai I Patel
Whole-time Director : Munjal Mahendrabhai Patel
Whole-time Director : Aashish R Patel
Independent Director : Saurin J Parikh
Non Executive Director : Rajnikant G Patel
Company Sec. & Compli. Officer : Trusha Shah
Independent Director : Seema Mehta
Independent Director : Nareshkumar Pirabhai Suthar
Registered Office: Lincoln House B/H Satyam Compe, Science City Road Sola,Ahmedabad,Gujarat-380060 Ph: 91-079-67778000
FAQs about Lincoln Pharmaceuticals Ltd
1. What's the Lincoln Pharmaceuticals Ltd share price today?
Lincoln Pharmaceuticals Ltd share price was Rs 461.30 at 04:01 PM IST on 1st Feb 2026. Lincoln Pharmaceuticals Ltd share price was up by 0.82% over the previous closing price of Rs 457.55. Lincoln Pharmaceuticals Ltd share price trend:
- Last 1 Month: Lincoln Pharmaceuticals Ltd share price moved down by 3.86% on BSE.
- Last 3 Months: Lincoln Pharmaceuticals Ltd share price moved down by 13.13% on BSE.
- Last 12 Months: Lincoln Pharmaceuticals Ltd share price moved down by 35.71% on BSE.
- Last 3 Years: Lincoln Pharmaceuticals Ltd share price moved up by 45.08% on BSE.
2. How can I quickly analyse the performance of the Lincoln Pharmaceuticals Ltd stock?
The performance of the Lincoln Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 11.54
- Price to book value ratio is 1.29
- Dividend yield of 0.39
- The EPS (trailing 12 months) of the Lincoln Pharmaceuticals Ltd stock is Rs 39.94
3. What is the market cap of Lincoln Pharmaceuticals Ltd?
Lincoln Pharmaceuticals Ltd has a market capitalisation of Rs 924 crore.
4. What is Lincoln Pharmaceuticals Ltd's 52-week high/low share price?
The Lincoln Pharmaceuticals Ltd’s 52-week high share price is Rs 804.70 and 52-week low share price is Rs 439.95.
5. Is the Lincoln Pharmaceuticals Ltd profitable?
On a consolidated basis, Lincoln Pharmaceuticals Ltd reported a profit of Rs 19.98 crore on a total income of Rs 170.60 crore for the quarter ended 2025.
6. Which are Lincoln Pharmaceuticals Ltd’s peers in the Health care sector?
Lincoln Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Bajaj Healthcare, NGL Fine Chem, Fermenta Biotec., Lincoln Pharma., Ind-Swift Labs., Fredun Pharma, Titan Biotech.
7. Who owns how much in Lincoln Pharmaceuticals Ltd?
Key changes to the Lincoln Pharmaceuticals Ltd shareholding are as follows:
- Promoter holding in Lincoln Pharmaceuticals Ltd has gone up to 49.78 per cent as of Dec 2025 from 49.78 per cent as of Mar 2025.